MIRA
INFORM REPORT
|
Report Date : |
09.07.2013 |
IDENTIFICATION DETAILS
|
Name : |
LEPUGE INSUMOS FARMACÊUTICOS LTDA |
|
|
|
|
Registered Office : |
Rua Faustino Negri, 273 Galpão 04 - Bairro Cooperativa 09851-720 - São
Bernardo Do Campo/Sp |
|
|
|
|
Country : |
Brazil |
|
|
|
|
Financials (as on) : |
31.12.2012 |
|
|
|
|
Date of Incorporation : |
01.08.1987 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Import and Distribution of Bulk Drugs, Chemicals and Related
Pharmaceutical Products. |
|
|
|
|
No. of Employees : |
21 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March, 31st, 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
Brazil |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
BRAZIL - ECONOMIC OVERVIEW
Characterized by large and well-developed agricultural,
mining, manufacturing, and service sectors, Brazil's economy outweighs that of
all other South American countries, and Brazil is expanding its presence in
world markets. Since 2003, Brazil has steadily improved its macroeconomic
stability, building up foreign reserves, and reducing its debt profile by
shifting its debt burden toward real denominated and domestically held
instruments. In 2008, Brazil became a net external creditor and two ratings agencies
awarded investment grade status to its debt. After strong growth in 2007 and
2008, the onset of the global financial crisis hit Brazil in 2008. Brazil
experienced two quarters of recession, as global demand for Brazil's
commodity-based exports dwindled and external credit dried up. However, Brazil
was one of the first emerging markets to begin a recovery. In 2010, consumer
and investor confidence revived and GDP growth reached 7.5%, the highest growth
rate in the past 25 years. Rising inflation led the authorities to take
measures to cool the economy; these actions and the deteriorating international
economic situation slowed growth to 2.7% in 2011, and 1.3% in 2012.
Unemployment is at historic lows and Brazil's traditionally high level of
income inequality has declined for each of the last 14 years. Brazil's
historically high interest rates have made it an attractive destination for
foreign investors. Large capital inflows over the past several years have
contributed to the appreciation of the currency, hurting the competitiveness of
Brazilian manufacturing and leading the government to intervene in foreign
exchange markets and raise taxes on some foreign capital inflows. President
Dilma ROUSSEFF has retained the previous administration's commitment to
inflation targeting by the central bank, a floating exchange rate, and fiscal
restraint. In an effort to boost growth, in 2012 the administration implemented
a somewhat more expansionary monetary policy that has failed to stimulate much
growth.
|
Source
: CIA |
Company name
LEPUGE INSUMOS
FARMACÊUTICOS LTDA
ADDRESSES
|
MAIN ADDRESS: |
RUA FAUSTINO NEGRI, 273 GALPÃO 04 - BAIRRO COOPERATIVA |
|
ZIP CODE/CITY: |
09851-720 - SÃO BERNARDO DO CAMPO/SP |
|
|
|
|
PHONE: |
11 2067-5600 RAMAL 5 |
|
FAX: |
11 2215-8823 |
|
E-MAIL: |
roberto@purifarma.com.br |
|
WEB SITE: |
www.purifarma.com.br |
|
BRANCHES: |
|
|
|
|
|
ADDRESS: |
RUA CORONEL CABRITA, 131 - JARDIM DA GLÓRIA |
|
ZIP CODE/CITY: |
01545-030 SÃO PAULO/SP |
|
PHONE: |
11 2067-5600 |
LEGAL DATA
|
MAIN ACTIVITIES: |
|
IMPORT AND DISTRIBUTION OF BULK DRUGS, CHEMICALS AND RELATED
PHARMACEUTICAL PRODUCTS. |
|
LEGAL FORM: |
LIMITED
LIABILITY COMPANY |
|
|
|
|
INCORPORATION DATE: |
01/08/1987 |
|
REGISTER DATE: |
14/08/1987 |
|
BALANCE SHEET FILING DATE: |
31/12 |
|
TAX CONTRIBUTOR NUMBER(CNPJ): |
57.884.835/0001-79 |
|
STATE REGISTER: |
635.653.743.114 |
|
|
|
|
SHARE CAPITAL: |
R$ 2.900.000,00 |
|
BOARD OF
DIRECTORS: |
|
|
|
|
|
VALDETE VIODRES TANAKA |
MANAGING PARTNER |
AUTHORIZED USE OF SIGNATURE
|
THE MANAGING PARTNER IS AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY. |
|
SHAREHOLDERS /
PARTNERS: |
|
|
|
|
|
VALDETE VIODRES TANAKA |
R$ 2.813.000,00 |
|
ROBERTO KAZUYUKI SHIBATA |
R$ 87.000,00 |
|
AFFILIATES /
SUBSIDIARIES: |
|
|
|
|
|
GEMINI INDUSTRIA DE INSUMOS FARMACÊUTICOS LTDA |
|
|
LEVIALE INDUSTRIA DE INSUMOS FARMACÊUTICOS LTDA |
|
|
JVT CONSTRUTORA E INCORPORADORA LTDA |
|
|
BISNAGO INDUSTRIA DE EMBALAGENS LTDA |
|
COMPANY'S BACKGROUND
|
THE SUBJECT WAS ESTABLISHED ON AUGUST 1, 1987 AS PURIFARMA
DISTRIBUIDORA QUIMICA E FARMACEUTICA LTDA., TO BE ENGAGED IN THE SAID LINE OF
BUSINESS. ON MAY 09, 2013 IT ADOPTED THE ABOVE MENTIONED NAME AND UP TO DATE
IT IS STILL OPERATING WITHIN THE GENERAL SCENE REPORTED HEREIN. PARTNERS: VALDETE VIODRES TANAKA: BRAZILIAN, MARRIED, ENTREPRENEUR, RESIDENTIAL
ADDRESS AT, RUA DAS PRIMAVEAS 255, CONDOMINIO BOUGUEVILLE II, ZIP CODE
11750-000, PERUÍBE/SP, HOLDER OF DOCUMENTS, RG 15.652.513 SSP-SP AND CPF
075.619.338-94; ROBERTO KAZUYUKI SHIBATA: BRAZILIAN, MARRIED, ENTREPRENEUR,
RESIDENTIAL ADDRESS AT, RUA GROELANDIA 318, JARDIM PARAÍSO, ZIP CODE
12235-090, SÃO JOSE DOS CAMPOS/SP, HOLDER OF DOCUMENTS, RG 5.830.867 SSP-SP
AND CPF 534.696.158-53. REMARKS: THE NUMBER OF EMPLOYEES HAS REDUCED AS SOME OF THEM HAS BEEN RELOCATED
TO OTHER COMPANIES OF THE GROUP. FURTHER DETAILS ARE SO FAR NOT KNOWN. |
|
PUBLIC
INFORMATION: |
|
NO DETRIMENTAL FILES WERE FOUND. |
FINANCIAL INFORMATION
|
GENERAL BALANCE
SHEETS AS OF 31/12/2012 AND 31/12/2011. |
|
( FIGURES ARE IN
REAIS ). |
|
ASSETS |
|
|
|
|
CURRENT: |
31/12/2012 |
31/12/2011 |
|
|
|
|
|
|
|
CASH AND BANKS |
2.575.478,08 |
2.095.159,98 |
|
|
CLIENTS |
583.929,00 |
2.319.959,47 |
|
|
INVENTORY |
512.890,57 |
581.148,83 |
|
|
JUDICIAL DEPOSITS |
5.346,90 |
|
|
|
|
---------------- |
---------------- |
|
|
TOTAL CURRENT ASSETS |
3.677.644,55 |
4.996.268,28 |
|
|
FIXED ASSETS: |
|
|
|
|
|
|
|
|
|
FIXED ASSETS |
354.222,28 |
105.989,70 |
|
|
INTANGIBLE |
18.225,15 |
18.225,15 |
|
|
DEFERRED |
25.080,30 |
25.080,30 |
|
|
|
---------------- |
---------------- |
|
|
TOTAL FIXED ASSETS |
397.527,73 |
149.295,15 |
|
|
|
================ |
================ |
|
|
TOTAL ASSETS |
4.075.172,28 |
5.145.563,43 |
|
|
LIABILITIES: |
|
|
|
|
CURRENT: |
31/12/2012 |
31/12/2011 |
|
|
|
|
|
|
|
SUPPLIERS |
769.831,30 |
57.572,95 |
|
|
TRIBUTARY OBLIGATIONS |
43.116,34 |
146.846,53 |
|
|
SOCIAL / LABOR OBLIGATIONS |
42.390,32 |
52.570,41 |
|
|
OBLIGATIONS/THIRD PARTIES |
2.460,00 |
2.460,00 |
|
|
|
---------------- |
---------------- |
|
|
TOTAL CURRENT LIABILITIES |
857.797,96 |
259.449,89 |
|
|
NET EQUITY: |
|
|
|
|
|
|
|
|
|
SHARE CAPITAL |
2.900.000,00 |
2.500.000,00 |
|
|
ACCRUED PROFIT (LOSS) |
317.374,32 |
2.386.113,54 |
|
|
|
---------------- |
---------------- |
|
|
TOTAL NET EQUITY |
3.217.374,32 |
4.886.113,54 |
|
|
|
================ |
================ |
|
|
TOTAL LIABILITIES |
4.075.172,28 |
5.145.563,43 |
|
|
PROFIT AND LOSS
ACCOUNTS AS OF 31/12/2012 AND 31/12/2011. |
|
( FIGURES ARE IN
REAIS ). |
|
|
31/12/2012 |
31/12/2011 |
|
|
|
|
|
|
|
GROSS SALES |
7.800.134,29 |
10.202.781,42 |
|
|
(-) TAXES ON SALES |
1.420.471,95 |
1.647.495,92 |
|
|
|
---------------- |
---------------- |
|
|
NET SALES |
6.379.662,34 |
8.555.285,50 |
|
|
(-) COST OF SOLD GOODS |
4.209.939,53 |
3.912.496,41 |
|
|
|
---------------- |
---------------- |
|
|
GROSS PROFIT |
2.169.722,81 |
4.642.789,09 |
|
|
OPERATING REVENUE (EXPENSE) |
-2.296.716,94 |
-2.328.705,90 |
|
|
FINANCIAL REVENUE(EXPENSE) |
-41.745,09 |
-38.990,12 |
|
|
|
---------------- |
---------------- |
|
|
OPERATIONAL PROFIT (LOSS) |
-168.739,22 |
2.275.093,07 |
|
|
NON-OPERATING RESULT |
|
302.000,00 |
|
|
PROFIT SHARING |
|
-222.000,00 |
|
|
|
---------------- |
---------------- |
|
|
NET PROFIT (LOSS) |
-168.739,22 |
2.355.093,07 |
|
|
MONTHLY SALES |
|||
|
|
2013 |
|
|
|
|
--------------------- |
|
|
|
JANUARY |
R$ 591.183,86 |
|
|
|
FEBRUARY |
R$ 804.782,03 |
|
|
|
MARCH |
R$ 898.553,98 |
|
|
|
APRIL |
R$ 1.137.653,95 |
|
|
|
MAY |
|
|
|
|
JUNE |
|
|
|
|
JULY |
|
|
|
|
AUGUST |
|
|
|
|
SEPTEMBER |
|
|
|
|
OCTOBER |
|
|
|
|
NOVEMBER |
|
|
|
|
DECEMBER |
|
|
|
|
TOTAL |
R$ 3.432.173,82 |
|
|
|
RATIOS: |
31/12/2012 |
31/12/2011 |
|
|
QUICK RATIO |
3,69 |
|
17,02 |
|
|
|
|
CURRENT RATIO |
4,29 |
|
19,26 |
|
|
|
|
ACCOUNTS RECEIVABLE TURNOVER |
10,93 |
TIMES |
3,69 |
TIMES |
|
|
|
DAYS' SALES IN RECEIVABLES |
32,95 |
DAYS |
97,62 |
DAYS |
|
|
|
INVENTORY TURNOVER |
8,21 |
TIMES |
6,73 |
TIMES |
|
|
|
ACCOUNTS PAYABLE PERIOD |
65,83 |
DAYS |
5,30 |
DAYS |
|
|
|
RETURN ON ASSETS |
1,57 |
TIMES |
1,66 |
TIMES |
|
|
|
SALES TURNOVER ON NET EQUITY |
1,98 |
TIMES |
1,75 |
TIMES |
|
|
|
NET WORTH TIE-UP |
,11 |
|
,02 |
|
|
|
|
INDEBTEDNESS |
,27 |
|
,05 |
|
|
|
|
EQUITY RATIO |
78,95 |
% |
94,96 |
% |
|
|
|
WORKING CAPITAL RATIO |
328,73 |
% |
1.825,72 |
% |
|
|
|
GENERAL SOLVENCY |
4,75 |
|
19,83 |
|
|
|
|
RETURN ON NET EQUITY |
-5,24 |
% |
48,20 |
% |
|
|
|
RETURN ON SALES (PROFIT MARGIN) |
-2,65 |
% |
27,53 |
% |
|
|
|
GROSS PROFIT MARGIN |
34,01 |
% |
54,27 |
% |
|
|
|
OPERATIONAL RESULT |
-2,65 |
% |
26,59 |
% |
|
|
|
SALES TURNOVER ON LIABILITIES |
7,44 |
TIMES |
32,97 |
TIMES |
|
|
|
FOREIGN CURRENCY ON ASSETS |
|
|
|
|
|
|
|
FOREIGN CURRENCY ON LIABILITIES |
|
|
|
|
|
|
|
EXCHANGE RATE: |
|
|
US$ 1,00 = R$ 2,05 |
- OFFICIAL RATE ON 23/05/2013 |
|
US$ 1,00 = R$ 2,04 |
- OFFICIAL RATE ON 31/12/2012 |
|
US$ 1,00 = R$ 1,87 |
- OFFICIAL RATE ON 31/12/2011 |
|
COMMENTS ON THE
FINANCIAL INFORMATION: |
|
FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS. THE FIGURES AVAILABLE SHOW A SATISFACTORY FINANCIAL STANDING. IT SHOWS
HIGH LIQUIDITY RATIOS AND POSITIVE WORKING CAPITAL, AS WELL AS LOW LEVEL OF
INDEBTEDNESS. ON THE OTHER HAND SALES DROPPED AND THE HIGH OPERATING EXPENSES
DROVE THE COMPANY TO MAKE LOSS. |
|
REAL ESTATE: |
OWNED PREMISES ARE VALUED AT R$ 648.000,00
|
VEHICLES: |
OWNED VEHICLES ARE VALUED AT R$ 73.874,77
|
MACHINES: |
OWNED MACHINES AND EQUIPMENTS ARE VALUED AT R$ 233.931,12
INSURANCE
|
INSURANCE COMPANY: |
PORTO SEGURO - CIA DE SEGUROS GERAIS |
|
COVERAGE: |
FIRE |
|
EXPIRATION: |
NO INFORMADO |
BANKING REFERENCES
|
|
BRANCH/PHONE: |
|
|
BANCO DO BRASIL S/A |
3322-7 / 11 2065-4059 |
|
|
BANCO ITAÚ (UNIBANCO) S/A |
0167 / 11 4004-4828 |
|
REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE
INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW
PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS.
ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY HAS
NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682 BRAZILIAN
CENTRAL BANK").
ACTIVITIES COMMENTS
THE SUBJECT IS ENGAGED IN THE IMPORT AND DISTRIBUTION OF BULK DRUGS,
CHEMICALS AND RELATED PHARMACEUTICAL PRODUCTS.
IMPORT AND EXPORT:
IMPORTS FROM:
SWITZERLAND, HOLLAND, CHINA, ITALY AND UNITED STATES.
EXPORTS TO:
DOES NOT EXPORT.
|
MAIN CLIENTS: |
|
|
|
|
|
|
|
DOMESTIC
CLIENTS: |
CITY: |
|
|
DERMAPELLE FARM. MANIPULAÇÃO LTDA |
SANTA MARIA/RS |
|
|
EUROFARMA LABORATÓRIOS LTDA |
SÃO PAULO/SP |
|
|
FARMÁCIA BIO FÓRMULAS LTDA |
SÃO PAULO/SP |
|
|
FARMÁCIA HERBANÁRIO LTDA |
POÇOS DE CALDAS/MG |
|
|
IMAFAR INST. MANIP. FARMACÊUTICAS LTDA |
SÃO PAULO/SP |
|
|
LABORATÓRIO GLOBO LTDA |
BELO HORIZONTE/MG |
|
|
MASE PROD QUIM E FARMACÊUTICA NACIONAL S/A |
SÃO PAULO/SP |
|
|
PHD FARMÁCIA DE MANIPULAÇÃO LTDA |
RIO DE JANEIRO/RJ |
|
|
PREFEITURA MINICIPAL ALGRETE |
ALEGRETE/RS |
|
|
PREFEITURA MINICIPAL DE CARAZINHO |
CARAZINHO/RS |
|
|
TATIANE MARAES SALOMÃO |
CAMPO GRANDE/MS |
|
|
UNIÃO QUIMICA FARMACEUTICA NACIONAL S/A |
EMBU GUAÇU/SP |
|
|
STAFF: |
|
|
|
THE COMPANY HAS: 21 EMPLOYEE(S) |
CONCEPT AND FULFILMENT
|
THE SUBJECT IS A WELL-ESTABLISHED COMPANY, OPERATING SINCE 1987. SO
FAR IT HAS A CLEAR TRADE HISTORY AND NO PAYMENT PROBLEMS ARE NOTED. THE COMPANY HAS TRADE RELATIONS WITH SOME LOCAL SUPPLIERS BUT UP TO
DATE ONLY SMALL PAYMENTS WERE REPORTED AND THE SUBJECT IS NOT SAID TO BE USER
OF TRADE CREDIT FACILITIES. |
|
MAIN SUPPLIERS: |
|
|
|
|
|
|
|
DOMESTIC
SUPPLIERS: |
|
PHONE: |
|
DIFFUCAP-CHEMOBRAS QUIM. LTDA |
|
21 5934-4223 |
|
NATURAL PHARMA PROD QUIM LTDA |
|
11 5575-0601 |
|
RP SCHERER BRASIL ENCAPSULAÇÕES |
|
15 225-2306 |
|
SINTEFINA IND. E COMÉRCIO LTDA |
|
11 3815-9191 |
|
FOREIGN
SUPPLIERS: |
COUNTRY: |
|
|
ANHUI CHEMICALS IMP. & EXP. CO. LTD |
CHINA |
|
|
C.N.C.I.E.C |
CHINA |
|
|
CHINA NATIONAL AERO-TECHNOLOGY |
CHINA |
|
|
CHINA XI`NA INTÌECONOMIC |
CHINA |
|
|
CIPLA LTD |
INDIA |
|
|
DIOSYNTH BV - AKZO NOBEL |
HOLLAND |
|
|
GENCOR PACIFIC LTD. |
CHINA |
|
|
HONEYWELL P.F.C. S.R.L. |
ITALY |
|
|
KYOWA HAKKO KOGGYO CO. LTD |
JAPAN |
|
|
LABORATORY MAG S.P.A |
ITALY |
|
|
PHARMACIA & UPJOHN WORLDWIDE |
UNITED STATES |
|
|
REFARMED CHEMICALS LTD |
SWITZERLAND |
|
|
RHENOCHEM AG. |
SWITZERLAND |
|
|
SELECTHEMIE AG |
SWITZERLAND |
|
|
UPJOHN CO. WORDWIDE-CHEMICAL MARKETING |
UNITED STATES |
|
|
PAYMENT HISTORY: |
|
01 SUPPLIER REPORTED PAYMENTS: |
|
TOTAL AMOUNT: R$ 610,00 |
|
|
|
AMOUNT OF INVOICES PAID: 2 |
|
TOTAL OF PROMPT PAYMENTS: 100% |
|
HIGHEST INVOICE: R$ 540,00 |
|
HIGHEST CREDIT: R$ 540,00 |
FINAL OPINION
|
THE SUBJECT IS A WELL-ESTABLISHED COMPANY IN BUSINESS FOR SEVERAL
YEARS. UP TO DATE IT HAS SATISFACTORY FINANCIAL STANDING, A CLEAR TRADE
HISTORY AND NORMAL PAYMENT BEHAVIOUR. BASED ON THE GENERAL INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD
TRADE RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN
TERMS AND AMOUNTS ADEQUATE TO THE COMPANY'S FINANCIAL STRENGTH. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.61.04 |
|
|
1 |
Rs.90.89 |
|
Euro |
1 |
Rs.78.27 |
INFORMATION DETAILS
|
Report Prepared
by : |
PRL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.